Eterna Therapeutics Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Eterna Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Eterna Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $3K, a 25% decline year-over-year.
  • Eterna Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$5K, a 109% decline year-over-year.
  • Eterna Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was -$3K, a 107% decline from 2022.
  • Eterna Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $45K, a 29.7% decline from 2021.
  • Eterna Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $64K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5K $3K -$1K -25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4K $4K -$1K -20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$3K -$4K -$44K -110% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $41K -$8K -$13K -260% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $54K $4K +$4K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $50K $5K +$5K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $45K $40K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $5K +$5K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0 +$19K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q1 2021 $19K $0 +$19K Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-01
Q4 2020 $0 $23K Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 -$19K -$38K -200% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $15K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$19K -$30K -273% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-20
Q3 2019 $19K +$9K +90% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q1 2019 -$55K $11K +$9K +450% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
Q4 2018 -$64K -$100K -$145K -322% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $81K $10K +$1K +11.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $80K $24K +$18K +300% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $62K $2K -$4K -66.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $66K $45K +$38K +543% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $28K $9K +$2K +28.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $26K $6K +$1K +20% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $25K $6K -$13K -68.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $38K $7K +$8K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $30K $7K +$22K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $8K $5K -$9K -64.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $17K $19K +$5K +35.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $12K -$1K -$57K -102% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 $69K -$15K -$36K -171% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $105K $14K +$17K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $88K $14K +$4K +40% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $84K $56K +$26K +86.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $58K $21K +$18K +600% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $40K -$3K -$8K -160% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $48K $10K +$2K +25% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $46K $30K +$139K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$93K $3K -$19K -86.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$74K $5K +$17K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$91K $8K -$8K -50% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$83K -$109K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $22K -$15K -40.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$12K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $16K +$5K +45.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q3 2011 $37K +$22K +147% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q1 2011 $11K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $15K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$13K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.